Neutrophil-to-Lymphocyte Ratio Predicts Prognosis in Castration-Resistant Prostate Cancer Patients Who Received Cabazitaxel Chemotherapy

Table 1

Patient characteristics ().

Variables	Total	NLR < 3.83	NLR ≥ 3.83	value
Number	47	27	20
Age (years)	71.4 (71.0 ± 7.0)	71.1 (71.0 ± 6.2)	72.1 (71.0 ± 8.2)	0.598
Baseline PSA (ng/mL)	150.3 (461.2 ± 789.9)	164.6 (478.4 ± 754.6)	126.9 (438.1 ± 854.7)	0.475
Parts of metastasis
Bone	47 (100.0%)	27 (100.0%)	20 (100.0%)
Lymph nodes	31 (65.9%)	17 (62.9%)	14 (70.0%)	0.624
Visceral	22 (46.8%)	10 (37.0%)	12 (60.0%)	0.124
Alb (mg/dL)	3.7 (3.6 ± 0.5)	3.8 (3.7 ± 0.4)	3.4 (3.4 ± 0.6)	0.110
LDH (IU/L)	269 (398.7 ± 496.7)	231 (399.7 ± 641.1)	362 (397.3 ± 186.5)	0.026
ALP (IU/L)	429 (794.9 ± 902.0)	373 (745.6 ± 855.8)	453 (861.6 ± 979.5)	0.297
Courses of docetaxel	9 (12.6 ± 11.1)	9 (11.3 ± 10.8)	7 (13.1 ± 10.9)	0.517